# \[e-drug\] Clinical trials and drugs: ethics and information

**URL:** <https://talk.edrugplus.org/t/e-drug-clinical-trials-and-drugs-ethics-and-information/30628>\
**Category:** e-drug\
**Created:** [October 6, 2008, 7:35pm UTC](https://talk.edrugplus.org/t/e-drug-clinical-trials-and-drugs-ethics-and-information/30628 "2008-10-06T19:35:27Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![Elena\_Garcia\_i\_Pujad](https://avatars.discourse-cdn.com/v4/letter/e/b4bc9f/32.png) [@Elena\_Garcia\_i\_Pujad](https://talk.edrugplus.org/u/Elena_Garcia_i_Pujad)\
**Post date:** [October 6, 2008, 7:35pm UTC](https://talk.edrugplus.org/t/e-drug-clinical-trials-and-drugs-ethics-and-information/30628/1 "2008-10-06T19:35:27Z")

</div>

E-DRUG: Clinical trials and drugs: ethics and information - 8th of October  
---------------------------------------------------------------------------------------------------------

Dear E-druggers,

The NGO Farmaceuticos Mundi and Medicus Mundi Catalunya are  
carrying out the awareness raising campaign called "Health for  
development". Its goal is to inform about the links between human  
rights, health and development in order to contribute, in the mid-term,  
to improving the Catalan health cooperation.

We will organize the round table: "Clinical trials and drugs: ethics and  
information" on 8 October at 7 pm in Barcelona Biomedical Research  
Park. At this round table we will touch upon subjects such as ethics  
in the clinical tests and informing society about drugs, which are two  
key items in the production chain of a medicine. For both of them,  
the right conditions must be met. Otherwise, the consequences,  
mainly for the populations of poor countries, can lead to a disaster.

In order to know what is a clinical test, which are its implementations  
and how we can spread research, we have invited Richard Smith. He  
advocates the improvement of access to scientific results, especially  
for developing countries, using a model of publications with open  
access to everyone. To talk about ethics in clinical tests we will have  
the participation of the Dutch organization Wemos, which publishes  
studies about clinical tests in poor countries. And to explain which  
information about drugs is transmitted to society, we have invited the  
German organization BUKO Pharma-Kampagne, which has a long  
experience in examining the marketing done and the information  
given by the pharmaceutical industry in connection with drugs.

Round Table. Clinical tests and drugs: ethics and information  
Introduced by: M Elena Garcia, project leader of the campaign  
"Health for development".  
Chaired by: Mag¡ Farr, clinical pharmacologist and researcher at the  
IMIM-Hospital del Mar.

The transparency and the relevance of clinical tests  
Richard Smith, chief executive of the United Health Europe and  
member of the board of directors of the scientific review PloS.

The ethics of the clinical tests in developing countries  
Informing society: publicity or information?  
Annelies den Boer, project leader of the organization Wemos.

Christian Wagner-Ahlfs, from the organization BUKO  
Pharma-Kampagne.  
More informatiom in the [1]website of the campaign (available in  
spanish and in catalan)

M Elena Garcia Pujadas  
Project leader  
Campaign "Health for development"  
[2]www.salutxdesenvolupament.org  
[3]www.saludxdesarrollo.org

References

1. [http://salutxdesenvolupament.org/ca](http://salutxdesenvolupament.org/ca)  
2. [http://www.salutxdesenvolupament.org/](http://www.salutxdesenvolupament.org/)  
3. [http://www.saludxdesarrollo.org/](http://www.saludxdesarrollo.org/)
